FI973484L - Menetelmä immuunivasteen stimuloimiseksi - Google Patents
Menetelmä immuunivasteen stimuloimiseksi Download PDFInfo
- Publication number
- FI973484L FI973484L FI973484A FI973484A FI973484L FI 973484 L FI973484 L FI 973484L FI 973484 A FI973484 A FI 973484A FI 973484 A FI973484 A FI 973484A FI 973484 L FI973484 L FI 973484L
- Authority
- FI
- Finland
- Prior art keywords
- stimulating
- immune system
- immune
- Prior art date
Links
- 210000000987 immune system Anatomy 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39623095A | 1995-03-01 | 1995-03-01 | |
| PCT/US1996/002839 WO1996026735A1 (en) | 1995-03-01 | 1996-02-29 | Method for stimulating an immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI973484A0 FI973484A0 (fi) | 1997-08-25 |
| FI973484L true FI973484L (fi) | 1997-10-24 |
Family
ID=23566398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI973484A FI973484L (fi) | 1995-03-01 | 1997-08-25 | Menetelmä immuunivasteen stimuloimiseksi |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0812206B1 (pt) |
| JP (1) | JP3657271B2 (pt) |
| KR (1) | KR19980702490A (pt) |
| AT (1) | ATE220331T1 (pt) |
| AU (1) | AU699291B2 (pt) |
| CA (1) | CA2213798C (pt) |
| DE (1) | DE69622259T2 (pt) |
| DK (1) | DK0812206T3 (pt) |
| ES (1) | ES2179187T3 (pt) |
| FI (1) | FI973484L (pt) |
| MX (1) | MX9706588A (pt) |
| NO (1) | NO973875L (pt) |
| NZ (1) | NZ305083A (pt) |
| PT (1) | PT812206E (pt) |
| WO (1) | WO1996026735A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1033406A4 (en) * | 1997-10-27 | 2005-03-09 | Sumitomo Electric Industries | INDUCER FOR THE PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY, EXPRESSION VECTOR CONTAINING THE GENE REQUIRED THEREFOR, AND METHOD FOR INDUCING THE PRODUCTION OF THE ANTIGEN-SPECIFIC ANTIBODY |
| JP2001526241A (ja) * | 1997-12-19 | 2001-12-18 | イミュネックス・コーポレーション | Ｈｉｖ感染に対する感受性を低下させるための方法 |
| ES2330017T3 (es) * | 1998-05-23 | 2009-12-03 | Leiden University Medical Center | Ligandos de cd40 y peptidos de ctl para tratar tumores. |
| DE60136334D1 (en) | 2000-02-02 | 2008-12-11 | Us Health | Cd40-ligand als adjuvant für respiratorisches syncytialvirus-impfstoff |
| ES2520026T3 (es) | 2006-09-18 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Composiciones y métodos para potenciar respuestas inmunitarias |
| CN102037135A (zh) | 2007-10-30 | 2011-04-27 | 阿肯色大学评议会 | 增强对有鞭毛的细菌的免疫反应的组合物和方法 |
| AU2008318357B2 (en) | 2007-11-01 | 2015-01-22 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to eimeria |
| AU2011207331C1 (en) | 2010-01-21 | 2016-05-12 | The Texas A&M University System | Vaccine vectors and methods of enhancing immune responses |
| KR101881611B1 (ko) | 2010-06-09 | 2018-07-25 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 캄필로박터 감염을 감소시키기 위한 백신 및 방법 |
| US8778345B2 (en) | 2011-04-29 | 2014-07-15 | Apexigen, Inc. | Anti-CD40 antibodies |
| EP2914627B1 (en) | 2012-10-30 | 2021-04-07 | Apexigen, Inc. | Anti-cd40 antibodies and methods of use |
| SG10202109925TA (en) | 2013-02-14 | 2021-10-28 | Univ Arkansas | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
| AU2014239557B2 (en) | 2013-03-15 | 2019-01-03 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
| EP3744340A3 (en) | 2015-07-16 | 2021-03-03 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
| JP7038064B2 (ja) | 2016-04-18 | 2022-03-17 | セルデックス セラピューティクス インコーポレイテッド | ヒトｃｄ４０に結合するアゴニスト抗体およびその使用 |
| SG11201809686SA (en) | 2016-05-03 | 2018-11-29 | Univ Arkansas | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993008207A1 (en) * | 1991-10-25 | 1993-04-29 | Immunex Corporation | Novel cytokine |
| WO1994004570A1 (en) * | 1992-08-21 | 1994-03-03 | Schering Corporation | Cd40 ligand, anti cd40 antibodies, and soluble cd40 |
| AU686230B2 (en) * | 1993-10-01 | 1998-02-05 | Immunex Corporation | Antibodies to CD40 |
-
1996
- 1996-02-29 PT PT96909555T patent/PT812206E/pt unknown
- 1996-02-29 DE DE69622259T patent/DE69622259T2/de not_active Expired - Lifetime
- 1996-02-29 NZ NZ305083A patent/NZ305083A/xx not_active IP Right Cessation
- 1996-02-29 WO PCT/US1996/002839 patent/WO1996026735A1/en active IP Right Grant
- 1996-02-29 MX MX9706588A patent/MX9706588A/es not_active IP Right Cessation
- 1996-02-29 JP JP52643096A patent/JP3657271B2/ja not_active Expired - Fee Related
- 1996-02-29 DK DK96909555T patent/DK0812206T3/da active
- 1996-02-29 AU AU53011/96A patent/AU699291B2/en not_active Ceased
- 1996-02-29 ES ES96909555T patent/ES2179187T3/es not_active Expired - Lifetime
- 1996-02-29 CA CA002213798A patent/CA2213798C/en not_active Expired - Fee Related
- 1996-02-29 AT AT96909555T patent/ATE220331T1/de not_active IP Right Cessation
- 1996-02-29 EP EP96909555A patent/EP0812206B1/en not_active Expired - Lifetime
- 1996-02-29 KR KR1019970705890A patent/KR19980702490A/ko not_active Withdrawn
-
1997
- 1997-08-22 NO NO973875A patent/NO973875L/no unknown
- 1997-08-25 FI FI973484A patent/FI973484L/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO973875D0 (no) | 1997-08-22 |
| FI973484A0 (fi) | 1997-08-25 |
| KR19980702490A (ko) | 1998-07-15 |
| NZ305083A (en) | 1999-06-29 |
| MX9706588A (es) | 1997-11-29 |
| NO973875L (no) | 1997-10-31 |
| AU699291B2 (en) | 1998-11-26 |
| DE69622259D1 (de) | 2002-08-14 |
| EP0812206B1 (en) | 2002-07-10 |
| EP0812206A1 (en) | 1997-12-17 |
| AU5301196A (en) | 1996-09-18 |
| JP3657271B2 (ja) | 2005-06-08 |
| CA2213798C (en) | 2001-02-06 |
| CA2213798A1 (en) | 1996-09-06 |
| PT812206E (pt) | 2002-11-29 |
| WO1996026735A1 (en) | 1996-09-06 |
| JPH11506418A (ja) | 1999-06-08 |
| DE69622259T2 (de) | 2003-03-27 |
| ES2179187T3 (es) | 2003-01-16 |
| DK0812206T3 (da) | 2002-09-09 |
| ATE220331T1 (de) | 2002-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI970059L (fi) | Menetelmä immunifunktion säätelemiseksi | |
| DE69517675D1 (de) | Fördersystem | |
| FI973484L (fi) | Menetelmä immuunivasteen stimuloimiseksi | |
| DE69510305D1 (de) | Fördersystem | |
| NO982598D0 (no) | System-plattform for kommunikasjonssystem | |
| DE69511811D1 (de) | Förderanlage | |
| ATE180744T1 (de) | Einschienen-fördersystem | |
| FI20050181L (fi) | Menetelmä valmistaa 21-kloorikortikosteroideja | |
| BR9607366A (pt) | Aparelho transportador | |
| DE69308230D1 (de) | Fördersystem | |
| DE59609250D1 (de) | Stimulationssystem | |
| FI922557L (fi) | Kuljetinjärjestelmä | |
| FI103133B1 (fi) | Menetelmä glukoosirepression modifioimiseksi | |
| FI945946L (fi) | Menetelmä fosforin poistamiseksi | |
| FI940846A0 (fi) | Menetelmä heraproteiinien eristämiseksi | |
| FI954832A0 (fi) | Uuttomenetelmä | |
| FI92347C (fi) | Menetelmä sähkömekaanisen lukitusjärjestelmän laitteiden ohjauksen aikaansaamiseksi | |
| FR2737930B1 (fr) | Procede et systeme de reconnaissance de caracteres manuscrits | |
| FI973057L (fi) | Klavulaanihapon uuttomenetelmä | |
| FI972450L (fi) | Menetelmä kappaleen käsittelemiseksi | |
| KR960014450U (ko) | 콘베이어 벨트 시스템 | |
| IT1281785B1 (it) | Metodo per il convogliamento di sigarette | |
| KR960037373U (ko) | 컨베이어 시스템 | |
| KR960028893U (ko) | 컨베이어시스템 | |
| KR970006255A (ko) | 클로로포름의 제조방법 |